Expression of IL-4 in Tumors: A Safety Surrogate to Predict Cancer Survival Associated With Biologic Therapies
- PMID: 38564398
- DOI: 10.36849/JDD.7941
Expression of IL-4 in Tumors: A Safety Surrogate to Predict Cancer Survival Associated With Biologic Therapies
Abstract
Interleukin (IL)-4-targeted therapies have revolutionized management of inflammatory dermatoses.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
